EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening

Lucie de Jonge, Esther Toes-Zoutendijk, Brechtje D M Koopmann, Marith van Schrojenstein Lantman, Brenda Franken-van Vorsselen, Christel Speijers, Huub van Ingen, Erwin Humer, Petra van der Groep, Marc Thelen, Iris Lansdorp-Vogelaar, Dutch National Colorectal Cancer Screening Working Group

Clinica Chimica Acta · 2024

DOI: 10.1016/j.cca.2024.119809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2024. Verfasst von Lucie de Jonge und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: l.dejonge.3@erasmusmc.nl. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Bias. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Public Health and the Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: As the impact of unmanaged bias (i.e. systematic source of inaccuracy) in fecal immunochemical test (FIT) analytical performance on long-term colorectal cancer (CRC) outcomes is unknown, we assessed the impact bias in FIT performance in an ongoing FIT-based CRC screening program. METHODS: This study consisted of two parts: cross-sectional observational data analysis to estimate change in short-term outcomes and microsimulation modelling to estimate change in long-term outcomes assuming different levels of bias by assuming 15 % lower up to 15 % higher Hemoglobin detected in the stool compared to observed. Two scenarios were considered: bias occurring 1) one-time only, due to the occasional bias associated with the FIT kits used in 2020 and 2) consistently due to a constant bias associated with the FIT kits used from 2020 onwards. RESULTS: With a hypothetical bias of -15 % to +15 %, we observed a positivity rate ranging from 6.7 % to 7.8 %, and a detection rate for CRC between 0.65 % and 0.68 %. Single biases in FIT performance resulted in less than 0.1 % change in long-term CRC screening outcomes, while consistent biases resulted in a much larger change (up to 1.4 % in CRC cases and CRC-related deaths and up to 2.07 % in total costs). Detecting lower Hemoglobin concentrations resulted in a relatively larger change on long-term CRC outcomes in comparison to positive bias. CONCLUSIONS: Because of the substantial impact of consistent FIT bias, it is important to set evidence-based acceptance criteria of bias on long-term CRC screening outcomes and in particular, the introduction of an asymmetrical or upward shifted tolerance interval for FIT bias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerBiasHumansCross-Sectional StudiesFecesFemaleMiddle AgedMaleAgedOccult BloodImmunochemistry

Stichwörter der Autor:innen

Allowable performance specificationsCRC screeningFITMicrosimulation modelling

Autor:innen und Institutionen

  • Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: l.dejonge.3@erasmusmc.nl.
  • Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands; Stichting kwaliteitsbewaking Medische Laboratoriumdiagnostiek (SKML), Nijmegen, The Netherlands.
  • Stichting kwaliteitsbewaking Medische Laboratoriumdiagnostiek (SKML), Nijmegen, The Netherlands.
  • Star-shl, Etten-Leur, The Netherlands.
  • Health Screening Organisation Bevolkingsonderzoek Nederland, The Netherlands.

Förderung

  • National Institute for Public Health and the Environment

Zitieren

APA

de Jonge, L., Toes-Zoutendijk, E., Koopmann, B. D. M., van Schrojenstein Lantman, M., Franken-van Vorsselen, B., Speijers, C., van Ingen, H., Humer, E., van der Groep, P., Thelen, M., Lansdorp-Vogelaar, I., & Dutch National Colorectal Cancer Screening Working Group (2024). Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.119809

Vancouver

de Jonge L, Toes-Zoutendijk E, Koopmann BDM, van Schrojenstein Lantman M, Franken-van Vorsselen B, Speijers C, et al. Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening. Clinica Chimica Acta. 2024. doi:10.1016/j.cca.2024.119809

BibTeX
@article{deJonge2024,
  author = {de Jonge, Lucie and Toes-Zoutendijk, Esther and Koopmann, Brechtje D M and van Schrojenstein Lantman, Marith and Franken-van Vorsselen, Brenda and Speijers, Christel and van Ingen, Huub and Humer, Erwin and van der Groep, Petra and Thelen, Marc and Lansdorp-Vogelaar, Iris and Dutch National Colorectal Cancer Screening Working Group, Dutch National Colorectal Cancer Screening Working Group},
  title = {Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screening},
  journal = {Clinica Chimica Acta},
  year = {2024},
  doi = {10.1016/j.cca.2024.119809}
}
Kostenlos starten →